InsiderTrades.com logo

BJDX Insider Trading

Insider Ownership Percentage: 0.08%
Insider Buying (Last 12 Months): $100,000.00
Insider Selling (Last 12 Months): $0.00

Bluejay Diagnostics Insider Trading History Chart

This chart shows the insider buying and selling history at Bluejay Diagnostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Bluejay Diagnostics Share Price & Price History

Current Price: $1.72
Price Change: ▲ Price Increase of +0.01 (0.58%)
As of 05/20/2026 03:54 PM ET

This chart shows the closing price history over time for BJDX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Bluejay Diagnostics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/14/2026Donald R ChaseDirectorBuy12,500$2.00$25,000.0012,525View SEC Filing Icon  
3/14/2026Douglas Clark WurthDirectorBuy12,500$2.00$25,000.0012,608View SEC Filing Icon  
3/14/2026Fred S ZeidmanDirectorBuy12,500$2.00$25,000.0012,500View SEC Filing Icon  
3/14/2026Indranil DeyCEOBuy12,500$2.00$25,000.0012,501View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Bluejay Diagnostics (NASDAQ:BJDX)

18.47% of Bluejay Diagnostics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BJDX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Bluejay Diagnostics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026Armistice Capital LLC65,000$43K0.0%N/A9.155%Search for SEC Filing on Google Icon
11/14/2025Sabby Management LLC29,628$45K0.1%-69.1%1.633%Search for SEC Filing on Google Icon
11/15/2024Anson Funds Management LP319,280$41K0.0%+359.3%1.929%Search for SEC Filing on Google Icon
8/15/2024CVI Holdings LLC66,165$46K0.0%N/A19.692%Search for SEC Filing on Google Icon
2/13/2024Armistice Capital LLC24,230$30K0.0%N/A1.954%Search for SEC Filing on Google Icon
11/15/2023Sabby Management LLC21,221$92K0.1%N/A1.711%Search for SEC Filing on Google Icon
2/14/2023Susquehanna International Group LLP84,890$29K0.0%N/A0.421%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Bluejay Diagnostics logo
Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Read More on Bluejay Diagnostics

Today's Range

Now: $1.72
Low: $1.64
High: $1.85

50 Day Range

MA: $1.89
Low: $1.67
High: $2.06

52 Week Range

Now: $1.72
Low: $1.62
High: $16.68

Volume

13,784 shs

Average Volume

152,731 shs

Market Capitalization

$1.77 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.72

Who are the company insiders with the largest holdings of Bluejay Diagnostics?

Bluejay Diagnostics' top insider shareholders include:
  1. Douglas Clark Wurth (Director)
  2. Donald R Chase (Director)
  3. Indranil Dey (CEO)
  4. Fred S Zeidman (Director)
  5. Gordon Winston Kinder (CFO)
  6. Kenneth R Fisher (CFO)
Learn More about top insider investors at Bluejay Diagnostics.